Here Are Some of the New Taxes Coming to Virginia Under Democrat Rule....
You Can See Why That Anti-ICE Lawsuit Filed by Minnesota Was Such a...
Utah Law Banning Inappropriate Material in School Libraries Faces Legal Challenge
The Traffic Tickets Looked Routine. The Pattern Behind Them Didn’t.
Pam Grier Tells The View About Her Childhood Experience With Racism in Ohio....
James Clyburn Just Said What About Republicans?
Here's How Much Money CA Is Losing As Hollywood Takes Production to Friendlier...
FBI Serves Subpoenas to Offices of Minnesota Gov. Tim Walz, AG Keith Ellison,...
American Jailed by Russia Over Firearm on Boat
Trump Dumps ATF Merger Plan
Danish Member of European Parliament Tells President Trump to 'F**k Off'
Gavin Newsom’s Davos Tantrum: Embarrassing Ramble About Trump, Europe, and Greenland
Guess How Much of Every Humanitarian Dollar the US Spends Actually Reaches the...
You Won't Believe These Deleted Posts by Mamdani's Equity Chief
There Is a Bombshell New Report Out About Trump's Immigration Policies
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos